Foamix Pharmaceuticals Ltd (FOMX)

[Whos_Who]

Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary, topical therapies to address unmet needs in dermatology, announced today that David Domzalski, Chief Executive Officer, will provide a corporate update at the Cantor Fitzgerald Global Healthcare Conference, taking place October 1-3 at the InterContinental New York Barclay Hotel.

Date: Tuesday, October 2
Time: 12:15pm Eastern Time
Location: InterContinental New York Barclay Hotel
Webcast: http://wsw.com/webcast/cantor7/fomx/